Pancreatic Cancer Clinical Trials
Find clinical trials for pancreatic cancer. Search for pancreatic cancer clinical trials in different cities and states across the United States.
Palliadelic TreatmentPalliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
Sponsor:
University of Nebraska
Location:
Code:
NCT05220046
Conditions
Pancreas Cancer
Biliary Tract Cancer
Psychological Distress
Gastrointestinal Cancer
Eligibility Criteria
Sex: All
Age: 19 - 70+
Healthy Volunteers: Not accepted
Interventions
Psilocybin
ASP2138 with Cancer TreatmentsA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Sponsor:
Astellas Pharma Global Development, Inc.
Location:
Code:
NCT05365581
Conditions
Gastric Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ASP2138
Pembrolizumab
Oxaliplatin
Leucovorin
Fluorouracil
Neoadjuvant ChemotherapyEvaluating the Response to Neoadjuvant Chemotherapy With Circulating Tumor DNA in Pancreatic Cancer
Sponsor:
Central DuPage Hospital
Location:
Code:
NCT04616131
Conditions
Pancreas Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Hepatic Artery ChemotherapyHepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
Sponsor:
Duke University
Location:
Code:
NCT05634720
Conditions
Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HA Chemotherapy
HBI-2438A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Sponsor:
HUYABIO International, LLC.
Location:
Code:
NCT05485974
Conditions
Lung Cancer
Non Small Cell Lung Cancer
Colorectal Cancer
Cancer of Pancreas
Colon Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HBI-2438
IMM-1-104A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
Sponsor:
Immuneering Corporation
Location:
Code:
NCT05585320
Conditions
Advanced Solid Tumor
Pancreatic Adenocarcinoma
Malignant Melanoma (Cutaneous)
Non-small Cell Lung Cancer (NSCLC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
IMM-1-104 Monotherapy (Treatment Group A)
IMM-1-104 + modified Gemcitabine/nab-Paclitaxel (Treatment Group B)
IMM-1-104 + modified FOLFIRINOX (Treatment Group C)
IMM-1-104 + dabrafenib (Treatment Group D)
IMM-1-104 + pembrolizumab (Treatment Group E)
Immunotherapy & Irreversible ElectroporationImmunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
Sponsor:
University of Louisville
Location:
Code:
NCT03080974
Conditions
Pancreatic Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Irreversible Electroporation
AOH1996AOH1996 for the Treatment of Refractory Solid Tumors
Sponsor:
City of Hope Medical Center
Location:
Code:
NCT05227326
Conditions
Refractory Malignant Solid Neoplasm
Osteosarcoma
Leiomyosarcomas
Synovial Sarcomas
Ovarian Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PCNA Inhibitor AOH1996
Observational StudyCollecting Medical Information and Tissue Samples from Patients with Pancreatic Cancer or Other Pancreatic Disorders
Sponsor:
Mayo Clinic
Location:
Code:
NCT00830557
Conditions
Islet Cell Tumor
Pancreatic Cancer
Pancreatic Disease
Acute Pancreatitis
Chronic Pancreatitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
medical chart review
survey administration
biospecimen collection
Observational StudyPancreatic Cancer Screening for At-risk Individuals
Sponsor:
Beth Israel Deaconess Medical Center
Location:
Code:
NCT05006131
Conditions
Pancreatic Cancer, Adult
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Screening for pancreatic cancer